Can a 90-Day online program improve your heart health?
NCT ID NCT07572721
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a 90-day fully virtual lifestyle program for adults aged 30-60 who are sedentary and at risk for heart disease. Participants exercise via Peloton, take daily supplements (Omega-3, Vitamin D3, Magnesium, fiber), and use wearable devices to track activity and sleep. The goal is to see if this approach helps with weight loss and improves cardiovascular health markers like waist size and blood sugar.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multicomponent lifestyle intervention (exercise, supplements, wearable tracking, education)
What this could lead to
If successful, this could show that a fully virtual lifestyle program helps people manage weight and improve heart health markers like cholesterol and blood sugar.
What could go wrong
This is a small, early study with no control group, so results may not be due to the intervention. It relies on self-reporting and may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR RISK FACTOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alethios
San Francisco, California, 94104, United States